Infections as a major preventable cause of human cancer
Open accessAbstract
Abstract. Kuper H, Adami H‐O & Trichopoulos D (Harvard School of Public Health, Boston, MA, USA; Karolinska Institute, Stockholm, Sweden; University of Athens Medical School, Greece). Infections as a major preventable cause of human cancer (Internal Medicine in the 21st Century). J Intern Med 2000; 248: 171–183. Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many cancers arise from sites of infection, chronic irritation and inflammation.
“Many cancers arise from sites of infection, chronic irritation and inflammation.”
From Inflammation and cancer (2002) · cites this paper as [11]
Tumour cells produce various cytokines and chemokines that attract leukocytes.
“Tumour cells produce various cytokines and chemokines that attract leukocytes.”
From Inflammation and cancer (2002) · cites this paper as [11]
H. pylori is established as a definite carcinogen for the development of gastric cancer, the second most common type of cancer globally, and DNA damage resulting from chronic inflammation is believed the mechanism.
“The Gram-negative bacterium H. pylori is established as a definite carcinogen for the development of gastric cancer — the second most common type of cancer globally11,29 — and DNA damage resulting from chronic inflammation is believed the mechanism32.”
From Inflammation and cancer (2002) · cites this paper as [11]
Neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines.
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [11]
Upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year.
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
Many malignancies are initiated by infections.
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,761 · see citing works
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,302 · see citing works
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974 · see citing works
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,989 · see citing works
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856 · see citing works
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562 · see citing works
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.bloodjournal503481 · Cited by 2,315 · see citing works
Helicobacter pylori Infection and Gastric Lymphoma
Parsonnet, J., Hansen, S., Rodríguez, L. V., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich∥, N., Vogelman∥, J. H., & FRIEDMAN, G. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301803 · Cited by 1,826 · see citing works
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402 · see citing works
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297 · see citing works
Münger, K., Werness, B. A., Dyson, N. J., Phelps, W. C., Harlow, E. E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 1,204 · see citing works
An international association between Helicobacter pylori infection and gastric cancer
The EUROGAST Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)90938-d · Cited by 1,158 · see citing works
Moore, P. S., & Chang, Y. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321801 · Cited by 1,095 · see citing works
IARC monographs on the evaluation of carcinogenic risks to humans
International Agency for Research on Cancer (1996) · Analytica Chimica Acta · doi:10.1016/s0003-2670(97)89591-8 · Cited by 1,091 · see citing works
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B. M., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6 · Cited by 1,088 · see citing works
Ohshima, H., & Bartsch, H. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90245-3 · Cited by 1,050 · see citing works
Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?
Beral, V., Peterman, T. A., Berkelman, R. L., & Jaffe, H. W. (1990) · The Lancet · doi:10.1016/0140-6736(90)90001-l · Cited by 1,046 · see citing works
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 903 · see citing works
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879 · see citing works
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 823 · see citing works
Huerta, G. T., & Villasana, J. E. M. (1988) · PubMed · Cited by 802 · see citing works
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
Gao, S., Kingsley, L., Li, M. O., Zheng, W., Parravicini, C., Ziegler, J. L., Newton, R., Rinaldo, C. R., Saah, A. J., Phair, J., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-925 · Cited by 793 · see citing works
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725 · see citing works
Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection
Martin, J. N., Ganem, D. E., Osmond, D. H., Page, K. A., Macrae, D., & Kedes, D. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381403 · Cited by 712 · see citing works
Oore, P. A. S. M., & Hang, Y. (1995) · Cited by 667 · see citing works
Epidemiology of Hodgkin's Disease
MacMahon, B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92483-5 · Cited by 483 · see citing works
Jones, D. L., Alani, R. M., & Münger, K. (1997) · Genes & Development · doi:10.1101/gad.11.16.2101 · Cited by 462 · see citing works
The Pathogenesis of Burkitt's Lymphoma
MAGRATH, I. T. (1990) · Advances in cancer research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 461 · see citing works
Hodgkin's Disease and Epstein-Barr Virus
Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich∥, N., Polk, B. F., & Vogelman∥, J. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201103 · Cited by 445 · see citing works
The influence of age on the development of the hepatitis B carrier state
Edmunds, W. J., Medley, G. F., Nokes, D. J., Hall, A. J., & Whittle, H. (1993) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1993.0102 · Cited by 425 · see citing works
Harwood, C. A., Surentheran, T., McGregor, J., Spink, P. J., Leigh, I. M., Breuer, J., & Proby, C. M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200007)61:3 · Cited by 423 · see citing works
Ray, R., Lagging, M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 401 · see citing works
Blaser, M. J., Chyou, P.-H., & Nomura, A. M. Y. (1995) · PubMed · Cited by 398 · see citing works
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 390 · see citing works
Global programme for control of hepatitis B infection
Kane, M. (1995) · Vaccine · doi:10.1016/0264-410x(95)80050-n · Cited by 384 · see citing works
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 366 · see citing works
Hepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with Cirrhosis
Simonetti, R. G., Cammà, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., Fiorentino, G., Craxı̀, A., Ciccaglione, A. R., Giuseppetti, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-97 · Cited by 352 · see citing works
Shiratori, Y. (1995) · Hepatology · doi:10.1016/0270-9139(95)90605-3 · Cited by 347 · see citing works
Hepatitis B virus and hepatocellular carcinoma
Arbuthnot, P. B., & Kew, M. (2001) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2001.iep178.x · Cited by 308 · see citing works
HCV-associated liver cancer without cirrhosis
Mitri, M. S. D., Pisi, E., Poussin, K., Paterlini-Bréchot, P., Bréchot, C., Baccarini, P., D’Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 292 · see citing works
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276 · see citing works
Shiratori, Y., Shiina, S., Imamura, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840220403 · Cited by 266 · see citing works
Suppression of Apoptotic Cell Death by Hepatitis C Virus Core Protein
Ray, R. B., Meyer, K., & Ray, R. (1996) · Virology · doi:10.1006/viro.1996.0644 · Cited by 265 · see citing works
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
Ray, R. B., Lagging, M., Meyer, K., Steele, R., & Ray, R. (1995) · Virus Research · doi:10.1016/0168-1702(95)00034-n · Cited by 253 · see citing works
The control of schistosomiasis. Second report of the WHO expert committee
Sturrock, R. F. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90322-h · Cited by 248 · see citing works
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929 · Cited by 237 · see citing works
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
Lechner, M. S., & Laimins, L. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4262-4273.1994 · Cited by 228 · see citing works
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor
Matsumoto, M., Hsieh, T., Zhu, N., VanArsdale, T. L., Hwang, S. B., Jeng, K.-S., Gorbalenya, A. E., Lo, S., Ou, J.-H. J., Ware, C. F., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1301-1309.1997 · Cited by 217 · see citing works
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L., & McCance, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00546.x · Cited by 211 · see citing works
Ensoli, B. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00037-3 · Cited by 202 · see citing works
Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma
Kaklamani, E. (1991) · JAMA · doi:10.1001/jama.1991.03460150078027 · Cited by 198 · see citing works
Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma
Dm, P., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'Abbé, K. A., & Wild, C. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480302 · Cited by 191 · see citing works
Interassay Correlation of Human Herpesvirus 8 Serologic Tests
Rabkin, C. S., Schulz, T. F., Whitby, D., Lennette, E. T., Magpantay, L. I., Chatlynne, L. G., & Biggar, R. J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515649 · Cited by 189 · see citing works
Atherton, J. C. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011662 · Cited by 188 · see citing works
Epidemiology of Human T-Cell Leukemia/Lymphoma Virus
Blattner, W. A., Blayney, D. W., Robert-Guroff, M., Samgadharan, M. G., Kalyanaraman, V. S., Sarin, P. S., Jaffe, E. S., & Gallo, R. C. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.3.406 · Cited by 179 · see citing works
H. pylori, the most common bacterial infection in Africa: a random serological study.
Holcombe, C., Omotara, B. A., Eldridge, J., & Jones, D. M. (1992) · PubMed · Cited by 177 · see citing works
JEWERS, R. J., Hildebrandt, P., Ludlow, J. W., Kell, B., & McCance, D. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1329-1335.1992 · Cited by 174 · see citing works
久保田, 由., 今山, 修., 三原, 公., 安元, 慎., 村上義之, 堀, 嘉., & Tatsuya, U. Z. A. (1992) · The Nishinihon Journal of Dermatology · Cited by 173 · see citing works
Global programme for control of hepatitis B infection
Kane, M. (1995) · Vaccine · doi:10.1016/0264-410x(95)93547-m · Cited by 165 · see citing works
Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
Thomas, J. T., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1131-1137.1998 · Cited by 162 · see citing works
Stuver, S. O., Taehibana, N., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K., & Mueller, N. E. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.1.57 · Cited by 160 · see citing works
Francis, D. A., Schmid, S. I., & Howley, P. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2679-2686.2000 · Cited by 156 · see citing works
Haswell, M., Satarug, S., Tsuda, M., Mairiang, E., Esumi, H., Sithithaworn, P., Mairiang, P., Saitoh, M., Yongvanit, P., & Elkins, D. B. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90244-5 · Cited by 140 · see citing works
Quasispecies in viral persistence and pathogenesis of hepatitis C virus
Forns, X., Purcell, R. H., & Bukh, J. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01590-5 · Cited by 139 · see citing works
How is Helicobacter pylori Transmitted?
Cave, D. R. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)80004-2 · Cited by 137 · see citing works
Hepatitis b Viruses and Hepatocellular Carcinoma
Buendia, M. A. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60306-1 · Cited by 137 · see citing works
Rosin, M. P., Zaki, S. S. A., Ward, A. J., & Anwar, W. A. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90248-8 · Cited by 132 · see citing works
Overview of the Epidemiology of Immunodeficiency-Associated Cancers
Beral, V., & Newton, R. (1998) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024164 · Cited by 131 · see citing works
Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., & Howley, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5100-5105.1992 · Cited by 129 · see citing works
Epidemiology of Hodgkin's disease
Cole, P. (1972) · JAMA · doi:10.1001/jama.222.13.1636 · Cited by 128 · see citing works
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
Wang, W. L., London, W. T., & Feitelson, M. A. (1991) · PubMed · Cited by 125 · see citing works
The epidemiology of HTLV-I infection
Mueller, N. E. (1991) · Cancer Causes & Control · doi:10.1007/bf00052359 · Cited by 122 · see citing works
Evans, A. S., & Gutensohn, N. M. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340203 · Cited by 118 · see citing works
Balsano, C., Avantaggiati, M. L., Natoli, G., Marzio, E. D., Will, H., Perricaudet, M., & Levrero, M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90379-l · Cited by 118 · see citing works
Trichopoulos, D., Τζώνου, Α., Kaklamani, E., Zavitsanos, X., Koumantaki, Y., Day, N., Muñóz, N., & Trichopoulou, A. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390109 · Cited by 114 · see citing works
Self-citationDistinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma
Rowe, M., Rooney, C. M., Rickinson, A. B., Lenoir, G., Rupani, H., Moss, D. J., Stein, H., & Epstein, M. A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350404 · Cited by 110 · see citing works
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929-1938.1994 · Cited by 104 · see citing works
Hepatitis C Virus and Hepatocellular Carcinoma
Colombo, M. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007116 · Cited by 102 · see citing works
Viruses and cancer causal associations
Evans, A. S., & Mueller, N. E. (1990) · Annals of Epidemiology · doi:10.1016/1047-2797(90)90020-s · Cited by 100 · see citing works
Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis.
Cohen, S. M., Purtilo, D. T., & Ellwein, L. B. (1991) · PubMed · Cited by 95 · see citing works
Risk Factors for Adult T-Cell Leukemia Among Carriers of Human T-Lymphotropic Virus Type I
Hisada, M., Okayama, A., Shioiri, S., Spiegelman, D. L., Stuver, S. O., & Mueller, N. E. (1998) · Blood · doi:10.1182/blood.v92.10.3557 · Cited by 89 · see citing works
Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA.
Hino, O., Tabata, S., & Hotta, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9248 · Cited by 88 · see citing works
[Epidemiology of Hodgkin's disease].
István, L., & Giczy, S. (1979) · PubMed · Cited by 70 · see citing works
Kuper, H., Τζώνου, Α., Kaklamani, E., Hadziyannis, S. J., Tasopoulos, N., Λάγιου, Π., Trichopoulos, D., & Stuver, S. O. (2000) · Cancer Causes & Control · doi:10.1023/a:1008951901148 · Cited by 69 · see citing works
Self-citationThamavit, W., Pairojkul, C., Tiwawech, D., Ito, M., Shirai, T., & Ito, N. (1993) · Carcinogenesis · doi:10.1093/carcin/14.11.2415 · Cited by 69 · see citing works
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
Gerbitz, A., Mautner, J., Geltinger, C., Hörtnagel, K., Christoph, B., Asenbauer, H., Klobeck, G., Polack, A., & Bornkamm, G. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202468 · Cited by 60 · see citing works
Newton, R. C. (2000) · Annals of Oncology · doi:10.1023/a:1008381703687 · Cited by 56 · see citing works
Morozov, A., Shiyanov, P. A., Barr, E., Leiden, J. M., & Raychaudhuri, P. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3451-3457.1997 · Cited by 54 · see citing works
Zacny, V. L., Wilson, J., & Pagano, J. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8043-8051.1998 · Cited by 54 · see citing works
The decline in the incidence of stomach cancer in sweden 1960‐1984: A birth cohort phenomenon
Hansson, L., Bergström, R., Sparjén, P., & Adami, H. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470405 · Cited by 49 · see citing works
Self-citationRisk Factors for Adult T-Cell Leukemia Among Carriers of Human T-Lymphotropic Virus Type I
Hisada, M., Okayama, A., Shioiri, S., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3557.422k09_3557_3561 · Cited by 46 · see citing works
Lanier, A. P., Henle, W., Bender, T. R., Henle, G., & Talbot, M. L. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260203 · Cited by 42 · see citing works
Loss of imprinting of igf2 in renal-cell carcinomas
Oda, H., Kume, H., Shimizu, Y., Inoue, T., & Ishikawa, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3 · Cited by 33 · see citing works
Epidemiology of Hodgkin's disease
Rothman, H., & Freed, N. (1989) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1989-890612 · Cited by 32 · see citing works
Badawi, A. F., & Mostafa, M. H. (1993) · Journal of International Medical Research · doi:10.1177/030006059302100601 · Cited by 25 · see citing works
Molecular Biology of Human T-Cell Leukemia Virus Associated with Adult T-Cell Leukemia
Yoshida, M., Hattori, S., & Seiki, M. (1985) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-70113-9_11 · Cited by 23 · see citing works
Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma
Chan, C. K., Mueller, N. E., Evans, A. S., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich∥, N., Polk, B. F., & Vogelman∥, J. H. (1991) · Cancer Causes & Control · doi:10.1007/bf00053132 · Cited by 23 · see citing works
Shevchuk, I. N., Chekulayev, V. A., Moan, J. E., & Berg, K. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960917)67:6 · Cited by 22 · see citing works
The Epstein-Barr Virus and Malignancy: Molecular EvidencePreprint
Pagano, J. S. (1974) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1974.039.01.092 · Cited by 22 · see citing works
Human immunodeficiency virus infection and cancer
Newton, R., Beral, V., & Weiss, R. A. (1998) · Cancer surveys · Cited by 22 · see citing works
Hepatitis Viruses: Their Role in Human Cancer
Bradley, D. W. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.t01-1-99240.x · Cited by 21 · see citing works
Mythily, D. V., Krishna, S., & Tergaonkar, V. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-7-1707 · Cited by 18 · see citing works
Genetic heterogeneity and properties of hepatitis C virus.
Pawlotsky, J. (1998) · PubMed · Cited by 14 · see citing works
Retroviruses—Human Immunodeficiency Virus
Blattner, W. A., OʼBrien, T. R., & Mueller, N. E. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0036-4_24 · Cited by 13 · see citing works
Saito, K., Sullivan, D. E., Haruna, Y., Nd, T., Sn, T., & Gerber, M. A. (1997) · PubMed · Cited by 13 · see citing works
Ultrastructural characteristics of liver fluke associated human cholangiocarcinoma cell lines.
Sriurairatana, S., Tengchaisri, T., & Sirisinha, S. (1996) · PubMed · Cited by 11 · see citing works
Genomic Aberrations of Human Papillomavirus Recovered from Cervical Cancers
Pao, C. C., Yao, D.-S., Lin, C.-Y., Lee, S. C., Su, H. T., & Lin, S. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0707 · Cited by 7 · see citing works
Ultrastructure of hepatocyte abnormalities in perimetastatic areas.
Me, C., Hj, F., Márquez, A., Arias-Sosa, L. A., & Nl, D. (1998) · PubMed · Cited by 5 · see citing works
Becker, Y., & Hadar, J. (1983) · Springer eBooks · doi:10.1007/978-1-4613-3906-9_10 · Cited by 4 · see citing works
Factors related to the occurrence of gastric adenocarcinoma subtypes
Ekström, A. M. (2000) · Figshare · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 9
- 1 Parsonnet J. Introduction. In: Parsonnet J, ed. Microbes and Malignancy. New York: Oxford University Press. 1999: pp. 3-15.
- 7 zur Hausen H. Viral oncogenesis. In: Parsonnet J, ed. Microbes and Malignancy. New York: Oxford University Press. 1999: pp. 107-30.
- 10 Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61 : 362-6.
- 13 IARC, Hepatitis viruses. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France : IARC. 1994: Vol. 59.
- 22 Uchida T, Takahashi K, Tatsuno K, Dhingra U, Eliason JF. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes. Int J Cancer 1996; 67 : 892-7.
- 27 Pitot HC. The natural history of neoplastic development: the relation of experimental models to human cancers. Cancer 1982; 49 : 1206-11.
- 73 Chang Y. KSHM, Kaposi's Sarcoma, and Related Lymphoproliferative Disorders. In: Parsonnet J, ed. Microbes and Malignancy. New York: Oxford University Press. 1999: pp. 207-31.
- 92 Danesh J. Is Helicobacter pylori Infection a Cause of Gastric Neoplasia? In: Newton R, Beral V, Weiss RA, eds. Infections and Human Cancer. Plainview: Cold Spring Harbor Laboratory Press. 1999: pp. 263-90.
- 95 Ekstro ¨m A-M. Factors related to the occurence of gastrric adenocarcinoma subtypes. Doctoral Dissertation, Stockholm: Karolinska Institutet, 2000.
Cited by
Sorted by citations
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · see citing works
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,365 · see citing works
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,091 · see citing works
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · see citing works
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057 · see citing works
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000 · see citing works
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608 · see citing works
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1252 · Cited by 1,567 · see citing works
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515 · see citing works
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392 · see citing works
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
Yang, A.-P., Liu, J.-P., Tao, W.-Q., & Li, H.-M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106504 · Cited by 1,138 · see citing works
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 981 · see citing works
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 938 · see citing works
Wang, D. (2005) · Gut · doi:10.1136/gut.2004.047100 · Cited by 906 · see citing works
Liver Fluke Induces Cholangiocarcinoma
Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M. J., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040201 · Cited by 776 · see citing works
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775 · see citing works
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand‐Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4174 · Cited by 756 · see citing works
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · see citing works
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 663 · see citing works
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636 · see citing works
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., & Ostrand‐Rosenberg, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.284 · Cited by 539 · see citing works
Oxidative stress in prostate cancer
Khandrika, L., Kumar, B., Koul, S., MARONI, P. D., & Koul, H. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.011 · Cited by 528 · see citing works
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 581 · see citing works
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 476 · see citing works
Pantuck, A. J., Leppert, J. T., Zomorodian, N., Aronson, W. J., Hong, J., Barnard, R. J., Seeram, N. P., Liker, H. R., Wang, H., Elashoff, R. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2290 · Cited by 463 · see citing works
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
Hu, B., Elinav, E., Huber, S., Booth, C. J., Strowig, T., Jin, C., Eisenbarth, S. C., & Flavell, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016814108 · Cited by 452 · see citing works
Lewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 442 · see citing works
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 413 · see citing works
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
Raulet, D. H., & Guerra, N. (2009) · Nature reviews. Immunology · doi:10.1038/nri2604 · Cited by 396 · see citing works
Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prìeto, J., & Avila, M. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03704.x · Cited by 391 · see citing works
The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy
Lin, Y., Bai, L., Chen, W., & Xu, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903431069 · Cited by 380 · see citing works
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384 · see citing works
Hypoxia, inflammation, and the tumor microenvironment in metastatic disease
Finger, E. C., & Giaccia, A. J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9224-5 · Cited by 370 · see citing works
Immunosuppression associated with chronic inflammation in the tumor microenvironment
Wang, D., & DuBois, R. N. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv123 · Cited by 358 · see citing works
Rakoff-Nahoum, S. (2006) · PubMed Central · Cited by 343 · see citing works
Pushalkar, S., Ji, X., Li, Y., Estilo, C. L., Ramanathan, Y., Singh, B., Li, X., & Saxena, D. B. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-144 · Cited by 344 · see citing works
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
Wang, D., Wang, H., Brown, J. R., Daikoku, T., Wei, N., Shi, Q., Richmond, A. J., Strieter, R. M., Dey, S. K., & DuBois, R. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052124 · Cited by 337 · see citing works
Ben‐Baruch, A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 336 · see citing works
Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment
Sato, Y., Goto, Y., Narita, N., & Hoon, D. S. �. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0022-y · Cited by 317 · see citing works
Ying, H.-Q., Deng, Q.-W., He, B., Pan, Y.-Q., Wang, F., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2014) · Medical Oncology · doi:10.1007/s12032-014-0305-0 · Cited by 319 · see citing works
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 300 · see citing works
The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression
Lin, E. Y., Gouon–Evans, V., Nguyen, A., & Pollard, J. W. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020399802795 · Cited by 292 · see citing works
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
Alpar, H. O., Somavarapu, S., Atuah, K. N., & Bramwell, V. W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287 · see citing works
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S. C., Lam, W. L., & Bennewith, K. L. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 285 · see citing works
Bacteria and cancer: cause, coincidence or cure? A review
Mager, D. L. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-14 · Cited by 278 · see citing works
Houghton, J., & Wang, T. C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.037 · Cited by 279 · see citing works
The IκB kinase – a bridge between inflammation and cancer
Karin, M. (2008) · Cell Research · doi:10.1038/cr.2008.30 · Cited by 260 · see citing works
Azcárate-Peril, M. A., Sikes, M. L., & Bruno-Bárcena, J. M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2011 · Cited by 252 · see citing works
How bacteria could cause cancer: one step at a time
Lax, A. J., & Thomas, W. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02360-0 · Cited by 253 · see citing works
Hyperplastic gastric tumors induced by activated macrophages in COX‐2/mPGES‐1 transgenic mice
Oshima, H., Oshima, M., Inaba, K., & Taketo, M. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600170 · Cited by 252 · see citing works
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250 · see citing works
The Inflammatory Tumor Microenvironment and Its Impact on Cancer Development
de Visser, K. E., & Coussens, L. M. (2006) · KARGER eBooks · doi:10.1159/000092969 · Cited by 247 · see citing works
Hernández‐Ledesma, B., Hsieh, C. C., & de Lumen, B. O. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.053 · Cited by 242 · see citing works
Guha, S., & Majumder, K. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12531 · Cited by 244 · see citing works
Macrophage migration inhibitory factor (MIF): A promising biomarker
Grieb, G., Merk, M., Bernhagen, J., & Bucala, R. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.4.1453629 · Cited by 242 · see citing works
Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C., & Jiang, J. (2016) · Scientific Reports · doi:10.1038/srep39482 · Cited by 233 · see citing works
Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays
Costello, C. M., Mah, N., Häsler, R., Rosenstiel, P. C., Waetzig, G. H., Hahn, A., Lu, T. T., Gürbüz, Y. S., Nikolaus, S., Albrecht, M., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020199 · Cited by 231 · see citing works
A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis
Yang, S., Chu, S., Gao, Y., Ai, Q., Liu, Y., Li, X., & Chen, N. (2019) · Cells · doi:10.3390/cells8070738 · Cited by 237 · see citing works
Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer
Prasad, S., Phromnoi, K., Yadav, V. R., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Planta Medica · doi:10.1055/s-0030-1250111 · Cited by 229 · see citing works
Chronic immune response dysregulation in MDS pathogenesis
Barreyro, L., Chlon, T. M., & Starczynowski, D. T. (2018) · Blood · doi:10.1182/blood-2018-03-784116 · Cited by 226 · see citing works
Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors
Chan, A. A., Bashir, M., Rivas, M. N., Duvall, K., Sieling, P. A., Pieber, T. R., Vaishampayan, P., Love, S. M., & Lee, D. J. (2016) · Scientific Reports · doi:10.1038/srep28061 · Cited by 223 · see citing works
Estrogen action and prostate cancer
Nelles, J. L., Hu, W., & Prins, G. S. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.20 · Cited by 216 · see citing works
Evaluation of the association of chronic inflammation and cancer: Insights and implications
Nigam, M., Mishra, A. P., Deb, V. K., Dimri, D. B., Tiwari, V., BUNGAU, S. G., Bungău, A. F., & Radu, A.-F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115015 · Cited by 215 · see citing works
Deng, Q., He, B., Liu, X., Jin, Y., Ying, H., Pan, Y., Sun, H., Chen, J., Wang, F., Gao, T., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0409-0 · Cited by 204 · see citing works
Wang, W., Bergh, A. R. J., & Damber, J. (2004) · The Prostate · doi:10.1002/pros.20061 · Cited by 204 · see citing works
Meurman, J. H. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5195 · Cited by 190 · see citing works
Sexton, K., & Hattis, D. B. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9333 · Cited by 187 · see citing works
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
Morris, G., Berk, M., Walder, K. R., & Maes, M. H. J. (2015) · BMC Medicine · doi:10.1186/s12916-014-0259-2 · Cited by 179 · see citing works
Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer
Enzler, T., Gillessen, S., Manis, J. P., Ferguson, D. O., Fleming, J., Alt, F. W., Mihm, M. C., & Dranoff, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021258 · Cited by 179 · see citing works
Microbial diversity in saliva of oral squamous cell carcinoma
Pushalkar, S., Mane, S. P., Ji, X., Li, Y., Evans, C., Crasta, O. R., Morse, D. E., Meagher, R. J., Singh, A. K., & Saxena, D. B. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00773.x · Cited by 178 · see citing works
NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Liu, P., Lu, Z., Liu, L., Li, R., Liang, Z., Shen, M., Han, X., Ren, D., Ji, M., Yuan, S., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152925 · Cited by 173 · see citing works
Eiró, N. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i3.62 · Cited by 173 · see citing works
Abd-El-Fattah, A. A., Sadik, N. A. H., Shaker, O. G., & Aboulftouh, M. L. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9575-y · Cited by 171 · see citing works
Bodner, L., Manor, E., Shear, M., & van der Waal, I. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01058.x · Cited by 172 · see citing works
Carcinogenesis mechanisms of Fusobacterium nucleatum
Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.102 · Cited by 173 · see citing works
Qiao, H., Tan, X.-R., Li, H., Li, J., Chen, X., Li, Y., Li, W., Tang, L., Zhou, G., Zhang, Y., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2810 · Cited by 171 · see citing works
Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation
Wang, J. Q., Jeelall, Y. S., Ferguson, L. L., & Horikawa, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00367 · Cited by 169 · see citing works
Bioactive Food Peptides in Health and Disease
Hernandez-Ledesma, B., & Hsieh, C. (2013) · InTech eBooks · doi:10.5772/3318 · Cited by 168 · see citing works
Tumor Macroenvironment and Metabolism
Zoughbi, W. A., Huang, J., Paramasivan, G. S., Till, H., Pichler, M., Guertl‐Lackner, B., & Höefler, G. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.005 · Cited by 160 · see citing works
Heparanase and the hallmarks of cancer
Jayatilleke, K. M., & Hulett, M. D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02624-1 · Cited by 161 · see citing works
Goto, M. (2008) · PubMed · Cited by 154 · see citing works
Xanthorrhizol: a review of its pharmacological activities and anticancer properties
Oon, S. F., Nallappan, M., Tee, T. T., Shohaimi, S., Kassim, N. K., Fazry, S., & Cheah, Y. H. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0255-4 · Cited by 150 · see citing works
Taher, C., de Boniface, J., Mohammad, A., Religa, P., Hartman, J., Yaiw, K.-C., Frisell, J., Rahbar, A., & Söderberg‐Nauclér, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056795 · Cited by 150 · see citing works
If Cumulative Risk Assessment Is the Answer, What Is the Question?
Callahan, M. A., & Sexton, K. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9330 · Cited by 149 · see citing works
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
Ferdinande, L., Decaestecker, C., Verset, L., Mathieu, A., Lopez, X. M., Negulescu, A.-M., Maerken, T. V., Salmon, I. J., Cuvelier, C. A., & Demetter, P. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.513 · Cited by 148 · see citing works
Winans, B., Humble, M. C., & Lawrence, B. P. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.09.004 · Cited by 149 · see citing works
The impact of chemotherapy on morbidity due to schistosomiasis
Richter, J. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00032-9 · Cited by 146 · see citing works
Wang, L., Zhao, Y., Liu, Y. F., Akiyama, K., Chen, C., Qu, C., Jin, Y. J., & Shi, S. (2013) · Stem Cells · doi:10.1002/stem.1388 · Cited by 146 · see citing works
More Than Just a Periodontal Pathogen –the Research Progress on Fusobacterium nucleatum
Chen, Y., Huang, Z., Tang, Z., Huang, Y., Huang, M., Liu, H., Ziebolz, D., Schmalz, G., Jia, B., & Zhao, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.815318 · Cited by 144 · see citing works
The role of chemokines in intestinal inflammation and cancer
Wang, D., DuBois, R. N., & Richmond, A. J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.003 · Cited by 145 · see citing works
Bacterial toxins and cancer — a case to answer?
Lax, A. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1130 · Cited by 145 · see citing works
MicroRNAs in inflammatory lung disease - master regulators or target practice?
Oglesby, I. K., McElvaney, N. G., & Greene, C. M. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-148 · Cited by 145 · see citing works
Helicobacter species and liver diseases: association or causation?
Pellicano, R., Ménard, A., Rizzetto, M., & Mégraud, F. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70066-5 · Cited by 144 · see citing works
Lee, J. Y., Zhao, L., & Hwang, D. H. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00259.x · Cited by 142 · see citing works
The dual personalities of matrix metalloproteinases in inflammation
Nghia, T. V. L. (2006) · Frontiers in bioscience · doi:10.2741/2161 · Cited by 142 · see citing works
Sexton, K. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9020370 · Cited by 141 · see citing works
Kiga, K., Mimuro, H., Suzuki, M., Shinozaki‐Ushiku, A., Kobayashi, T., Sanada, T., Kim, M., Ogawa, M., Iwasaki, Y. W., Kayo, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms5497 · Cited by 141 · see citing works
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients
Hu, H. W., Yao, X., Xie, X., Wu, X., Zheng, C., Xia, W., & Ma, S. (2016) · World Journal of Urology · doi:10.1007/s00345-016-1864-9 · Cited by 140 · see citing works
Comorbidities in the management of patients with lung cancer
Leduc, C., Antoni, D., Charloux, A., Falcoz, P., & Quoix, É. (2017) · European Respiratory Journal · doi:10.1183/13993003.01721-2016 · Cited by 137 · see citing works
- Authors
- Kuper, H., Adami, H. ‐., & Trichopoulos, D.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 248
- Issue
- 3
- Pages
- 171-183
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2159454395
- Cited by
- 740
- References
- 109
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 23 · 2023: 44 · 2022: 29 · 2021: 39 · 2020: 36 · 2019: 42 · 2018: 32 · 2017: 41 · 2016: 35 · 2015: 37 · 2014: 32 · 2013: 44 · 2012: 30
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- infection, cancer prevention, carcinogenesis, chronic inflammation, oncogenes, tumour suppressor, immunosuppression, persistent infection, tumor latency
- MeSH terms
- Animals, Clonorchiasis, Humans, Neoplasms, Primary Prevention, Schistosomiasis, Virus Diseases, Helicobacter pylori, Helicobacter Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review